News, Short Squeeze, Breakout and More Instantly...
Novavax (NASDAQ: NVAX) reported its second-quarter results after the market closed on Monday. CEO Stanley Erck stated in a press release announcing those results, "We are pleased with our progress since the start of the second quarter." But investors certainly aren't pleased. No...
Novavax (NASDAQ: NVAX) , an up-and-down coronavirus stock, had a down day on Monday. The vaccine specialist's share price took a 5% hit after the company reported earnings that fell short of expectations. For its second quarter, Novavax earned just under $186 million in total re...
Shares of Novavax Inc ( NASDAQ: NVAX ) tanked nearly 35% in extended trading on Monday after the biotech company reported thoroughly disappointing results for its fiscal second quarter and lowered its annual sales outlook by 50%. Novavax Q2 financial highlights Lost $510.5...